NOTE vs CSGP vs SPGI vs VRSK vs GOVX

For growth investors, CoStar Group, Inc.

(CSGP) is the stronger pick with 18. 7% revenue growth year-over-year, versus -37. 1% for GeoVax Labs, Inc. (GOVX). Verisk Analytics, Inc. (VRSK) offers the better valuation at 26. 9x trailing P/E (22. 9x forward), making it the more compelling value choice. Analysts rate CoStar Group, Inc. (CSGP) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Verisk Analytics, Inc.

(VRSK) is the cheapest at 26. 9x versus CoStar Group, Inc. at 2107. 2x. On forward P/E, S&P Global Inc. is actually cheaper at 21. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: S&P Global Inc. wins at 2. 51x versus Verisk Analytics, Inc. 's 2. 68x.

Over the past 5 years, S&P Global Inc.

(SPGI) delivered a total return of +14. 2%, compared to -99. 8% for FiscalNote Holdings, Inc. (NOTE). Over 10 years, the gap is even starker: SPGI returned +337. 1% versus NOTE's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Verisk Analytics, Inc.

(VRSK) is the lower-risk stock at -0. 04β versus FiscalNote Holdings, Inc. 's 2. 79β — meaning NOTE is approximately -7863% more volatile than VRSK relative to the S&P 500. On balance sheet safety, FiscalNote Holdings, Inc. (NOTE) carries a lower debt/equity ratio of 0% versus 16% for Verisk Analytics, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), CoStar Group, Inc.

(CSGP) is pulling ahead at 18. 7% versus -37. 1% for GeoVax Labs, Inc. (GOVX). On earnings-per-share growth, the picture is similar: GeoVax Labs, Inc. grew EPS 81. 4% year-over-year, compared to -660. 2% for FiscalNote Holdings, Inc.. Over a 3-year CAGR, GOVX leads at 212. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Verisk Analytics, Inc.

(VRSK) is the more profitable company, earning 29. 6% net margin versus -862. 3% for GeoVax Labs, Inc. — meaning it keeps 29. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VRSK leads at 44. 6% versus -869. 3% for GOVX. At the gross margin level — before operating expenses — GOVX leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, S&P Global Inc. (SPGI) is the more undervalued stock at a PEG of 2. 51x versus Verisk Analytics, Inc. 's 2. 68x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, S&P Global Inc. (SPGI) trades at 21. 8x forward P/E versus 25. 8x for CoStar Group, Inc. — 4. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CSGP: 77. 0% to $61. 91.

In this comparison, VRSK (1.

0% yield), SPGI (0. 9% yield) pay a dividend. NOTE, CSGP, GOVX do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Verisk Analytics, Inc.

(VRSK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 04), 1. 0% yield, +137. 1% 10Y return). FiscalNote Holdings, Inc. (NOTE) carries a higher beta of 2. 79 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VRSK: +137. 1%, NOTE: -99. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (NOTE (Technology) and CSGP (Real Estate) and SPGI (Financial Services) and VRSK (Industrials) and GOVX (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: NOTE is a small-cap quality compounder stock; CSGP is a mid-cap high-growth stock; SPGI is a mid-cap quality compounder stock; VRSK is a mid-cap quality compounder stock; GOVX is a small-cap quality compounder stock. SPGI, VRSK pay a dividend while NOTE, CSGP, GOVX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.